CPSF6 and infection: While not targets of clinical infection, HEK293T and Jurkat T cells were nevertheless chosen due to accessibility of complementary datasets derived from LEDGF/p75- and CPSF6-depleted cells, or from cells infected with CA mutant viruses that are defective for CPSF6 binding [6,13,15].